Multiple Sclerosis
Zhittya Genesis Medicine believes that FGF-1, a natural human-growth factor capable of growing brand-new blood vessels, is a possible treatment for Multiple Sclerosis. By reestablishing blood flow to dysfunctional and leaky endothelial cells, thereby repairing the aforementioned ailments, Zhittya Genesis Medicine believes that symptoms of Multiple Sclerosis could be relieved and the disease could be treated.
Zhittya Regenerative Medicine believes that our biological drug FGF-1 could possibly treat, or even cure Multiple Sclerosis as seen by our video. FGF-1 is a biological drug that is native to the human body, and could trigger vascular growth to replenish cells that have been starved of nutrient and oxygen rich blood. We believe that a lack of blood flow could be the cause of MS.
Zhittya Genesis Medicine believes that the same drug, FGF-1, depicted in this video growing new blood vessels in a human heart in a US FDA Phase II Clinical Trial could be a possible treatment for multiple sclerosis. By reestablishing blood flow to blood-starved endothelial cells, giving them an oppurtunity to regrow and replenish, the principle reason behind MS could be treated and the symptoms could be relieved.